Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 55 clinical trials
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

The purpose of this trial is to compare the morbidity and mortality of CRS-HIPEC using mitomycin-C versus melphalan for colorectal peritoneal carcinomatosis. Morbidity and mortality will measured using the Comprehensive Complication Index (CCI) score, Common terminology criteria for adverse events (CTCAE version 4.03), and the Clavien-Dindo Classification.

mitomycin
metastasis
systemic chemotherapy
neutrophil count
hyperthermic intraperitoneal chemotherapy
  • 67 views
  • 17 Jun, 2022
  • 1 location
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

Most pediatric patients with solid tumors respond to initial high-dose, intensive therapy and complete treatment in remission. High-risk patients however, frequently have recurrent disease which is then treated with ad hoc regimens or early phase therapies with little benefit to the patient. Metronomic therapy (MC), defined as lower dose continuous …

sarcoma
platelet count
cyclophosphamide
cancer
neutrophil count
  • 0 views
  • 21 Jan, 2021
  • 2 locations
Register of Blood Stem Cell Transplantation (REBB3M)

Register of patients with blood stem cell transplantations (autologous, allogen).

cell transplantation
  • 4 views
  • 17 May, 2022
  • 1 location
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

This is a non-interventional, multi-national, observational, prospective patient registry to further evaluate the effectiveness and safety of dinutuximab beta - a monoclonal immunoglobulin G 1 (IgG1) antibody, to obtain information on survival, pain severity and incidence of neuro-toxicity, visual impairment, capillary leak syndrome, cardiovascular events, hypersensitivity reactions and long-term safety.

dinutuximab
high-risk neuroblastoma
  • 0 views
  • 27 Oct, 2021
  • 14 locations
A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

This is a single center, prospective cohort study to to evaluate the efficacy and safety of autologous hematopoietic stem cell transplantation(ASCT) bridging chimeric antigen receptor T (CART) cell therapy in the treatment of relapsed/refractory B-cell non-Hodgkin's lymphoma.

  • 0 views
  • 16 Jun, 2021
  • 1 location